Prevalence and impact of diabetes and prediabetes on presentation and complications of primary hyperaldosteronism at diagnosis

Table 3 Comparison of the pattern of clinical presentation, n (%)

Presentation	Non-diabetes (n = 30)	Prediabetes (n = 19)	T2DM (n = 29)	P value
Resistant hypertension	7 (23.3)	1 (5.35)	3 (10.3)	NS
Spontaneous hypokalemia with hypertension	15 (50)	11 (57.9)	15 (51.7)	NS
Adrenal incidentaloma with hypertension	2 (6.7)	2 (10.5)	2 (6.9)	NS
Resistant hypertension with diuretic induced hypokalemia	6 (20)	5 (26.3)	9 (31)	NS
Mean number of antihypertensives (mean ± SD)	3.0 ± 0.6	2.9 ± 0.6	3.1 ± 0.7	NS
No. of antihypertensives
1	1 (3.3)	1 (5.3)	1 (3.4)	NS
2	3 (1.0)	1 (5.3)	2 (6.9)
3	22 (73.3)	16 (84.2)	19 (65.5)
4	4 (13.3)	1 (5.3)	6 (20.7)
5	0 (0)	0 (0)	1 (3.4)

NS: Non-significant, P ≥ 0.05; P < 0.05: Statistically significant; T2DM: Type 2 diabetes mellitus.